Literature DB >> 29052621

Cancer treatment: Bacterial snack attack deactivates a drug.

Christian Jobin1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29052621     DOI： 10.1038/550337a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.

Authors:  Kosuke Mima; Reiko Nishihara; Zhi Rong Qian; Yin Cao; Yasutaka Sukawa; Jonathan A Nowak; Juhong Yang; Ruoxu Dou; Yohei Masugi; Mingyang Song; Aleksandar D Kostic; Marios Giannakis; Susan Bullman; Danny A Milner; Hideo Baba; Edward L Giovannucci; Levi A Garraway; Gordon J Freeman; Glenn Dranoff; Wendy S Garrett; Curtis Huttenhower; Matthew Meyerson; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Shuji Ogino
Journal:  Gut       Date:  2015-08-26       Impact factor: 23.059

Review 2.  Human nutrition, the gut microbiome and the immune system.

Authors:  Andrew L Kau; Philip P Ahern; Nicholas W Griffin; Andrew L Goodman; Jeffrey I Gordon
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.

Authors:  TaChung Yu; Fangfang Guo; Yanan Yu; Tiantian Sun; Dan Ma; Jixuan Han; Yun Qian; Ilona Kryczek; Danfeng Sun; Nisha Nagarsheth; Yingxuan Chen; Haoyan Chen; Jie Hong; Weiping Zou; Jing-Yuan Fang
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Authors:  Leore T Geller; Michal Barzily-Rokni; Tal Danino; Oliver H Jonas; Noam Shental; Deborah Nejman; Nancy Gavert; Yaara Zwang; Zachary A Cooper; Kevin Shee; Christoph A Thaiss; Alexandre Reuben; Jonathan Livny; Roi Avraham; Dennie T Frederick; Matteo Ligorio; Kelly Chatman; Stephen E Johnston; Carrie M Mosher; Alexander Brandis; Garold Fuks; Candice Gurbatri; Vancheswaran Gopalakrishnan; Michael Kim; Mark W Hurd; Matthew Katz; Jason Fleming; Anirban Maitra; David A Smith; Matt Skalak; Jeffrey Bu; Monia Michaud; Sunia A Trauger; Iris Barshack; Talia Golan; Judith Sandbank; Keith T Flaherty; Anna Mandinova; Wendy S Garrett; Sarah P Thayer; Cristina R Ferrone; Curtis Huttenhower; Sangeeta N Bhatia; Dirk Gevers; Jennifer A Wargo; Todd R Golub; Ravid Straussman
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

5.  Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.

Authors:  Rachel W Kasinskas; Neil S Forbes
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

6.  Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Authors:  Romain Daillère; Marie Vétizou; Nadine Waldschmitt; Takahiro Yamazaki; Christophe Isnard; Vichnou Poirier-Colame; Connie P M Duong; Caroline Flament; Patricia Lepage; Maria Paula Roberti; Bertrand Routy; Nicolas Jacquelot; Lionel Apetoh; Sonia Becharef; Sylvie Rusakiewicz; Philippe Langella; Harry Sokol; Guido Kroemer; David Enot; Antoine Roux; Alexander Eggermont; Eric Tartour; Ludger Johannes; Paul-Louis Woerther; Elisabeth Chachaty; Jean-Charles Soria; Encouse Golden; Silvia Formenti; Magdalena Plebanski; Mutsa Madondo; Philip Rosenstiel; Didier Raoult; Vincent Cattoir; Ivo Gomperts Boneca; Mathias Chamaillard; Laurence Zitvogel
Journal:  Immunity       Date:  2016-10-04       Impact factor: 31.745

7.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Authors:  Ayelet Sivan; Leticia Corrales; Nathaniel Hubert; Jason B Williams; Keston Aquino-Michaels; Zachary M Earley; Franco W Benyamin; Yuk Man Lei; Bana Jabri; Maria-Luisa Alegre; Eugene B Chang; Thomas F Gajewski
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

8.  Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Authors:  Marie Vétizou; Jonathan M Pitt; Romain Daillère; Patricia Lepage; Nadine Waldschmitt; Caroline Flament; Sylvie Rusakiewicz; Bertrand Routy; Maria P Roberti; Connie P M Duong; Vichnou Poirier-Colame; Antoine Roux; Sonia Becharef; Silvia Formenti; Encouse Golden; Sascha Cording; Gerard Eberl; Andreas Schlitzer; Florent Ginhoux; Sridhar Mani; Takahiro Yamazaki; Nicolas Jacquelot; David P Enot; Marion Bérard; Jérôme Nigou; Paule Opolon; Alexander Eggermont; Paul-Louis Woerther; Elisabeth Chachaty; Nathalie Chaput; Caroline Robert; Christina Mateus; Guido Kroemer; Didier Raoult; Ivo Gomperts Boneca; Franck Carbonnel; Mathias Chamaillard; Laurence Zitvogel
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

9.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

10.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.

Authors:  Ravid Straussman; Teppei Morikawa; Kevin Shee; Michal Barzily-Rokni; Zhi Rong Qian; Jinyan Du; Ashli Davis; Margaret M Mongare; Joshua Gould; Dennie T Frederick; Zachary A Cooper; Paul B Chapman; David B Solit; Antoni Ribas; Roger S Lo; Keith T Flaherty; Shuji Ogino; Jennifer A Wargo; Todd R Golub
Journal:  Nature       Date:  2012-07-26       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.